Cellphire, Inc.
15Patents
14Active
15Granted
61Portfolio score
Filing activity: Aug 12, 2005 → Mar 7, 2025 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8097403B2 | Freeze-dried platelets, method of making and method of use as a diagnostic agent | Chemistry; Metallurgy | 29 | Active |
| US7811558B2 | Use of stabilized platelets as hemostatic agent | Physics | 26 | Expired |
| US11529587B2 | Materials and methods for producing blood products | Chemistry; Metallurgy | 10 | Active |
| US11701388B2 | Thrombosomes as an antiplatelet agent reversal agent | Human Necessities | 7 | Active |
| US11752468B2 | Materials and methods for producing blood products | Chemistry; Metallurgy | 7 | Active |
| US11767511B2 | Platelets as delivery agents | Chemistry; Metallurgy | 6 | Active |
| US11813572B2 | Materials and methods for producing blood products | Chemistry; Metallurgy | 5 | Active |
| US12208122B2 | Methods of treating bleeding in a subject treated with an antiplatelet agent | Human Necessities | 2 | Active |
| US11965178B2 | Platelets loaded with anti-cancer agents | Chemistry; Metallurgy | 0 | Active |
| US12370219B2 | Platelet derivative compositions, and pluralities of containers containing same | Human Necessities | 0 | Active |
| US12378523B2 | Platelets as delivery agents | Chemistry; Metallurgy | 0 | Active |
| US11903971B2 | Treatment of von Willebrand disease | Chemistry; Metallurgy | 0 | Active |
| US12290532B2 | Treatment of von Willebrand disease | Chemistry; Metallurgy | 0 | Active |
| US12295972B2 | Methods using freeze-dried platelet derivative compositions for restoring hemostasis in a subject | Human Necessities | 0 | Active |
| US12419914B2 | Thrombosomes as an antiplatelet agent reversal agent | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.